Neil Kumar, CEO and President: BridgeBio Pharma BBIO Sell · Filed 23/02/21

Trade details

Type: Insider sale
Amount: $568,934.6
Shares · price: 44,798 sh · $12.70 a share
Held after: 4,813,197 sh
Stock: BridgeBio Pharma BBIO
Person: Neil KumarCEO and President
Trade date: 23/02/17
Filed: 23/02/21
Days to filing: 4 days

Sold 0.9% of holdings

Share of holding sold: 0.9%

BridgeBio Pharma trades, last 26 weeks

What else happened in BridgeBio Pharma around then

Filed or reported within 30 days of the trade day · 23/01/18~23/03/19

Neil Kumar's recent trades

Neil KumarDirector, Officer
Planned sale10b5-1 planBridgeBio Pharma
Planned sale10b5-1 plan
BridgeBio Pharma
BBIO
$2.5M
30,000 sh
$2.5M
Filed 08/19
Traded 08/19
Neil KumarDirector, Officer
Planned sale10b5-1 planBridgeBio Pharma
Planned sale10b5-1 plan
BridgeBio Pharma
BBIO
$2.8M
34,980 sh
$2.8M
Filed 08/18
Traded 08/18
Neil KumarCEO
Sell10b5-1 planBridgeBio Pharma
Sell10b5-1 plan
BridgeBio Pharma
BBIO
$1.1M
15,921 sh
$1.1M
Filed 06/08
Traded 06/04
Neil KumarCEO
Sell10b5-1 planBridgeBio Pharma
Sell10b5-1 plan
BridgeBio Pharma
BBIO
$1.1M
15,921 sh
$1.1M
Filed 06/08
Traded 06/04
Neil KumarCEO
Sell10b5-1 planBridgeBio Pharma
Sell10b5-1 plan
BridgeBio Pharma
BBIO
$572.7K
8,437 sh
$572.7K
Filed 06/08
Traded 06/05

Neil Kumar, CEO — sold $568.9K of BridgeBio Pharma BBIO · 0.9% of holdings | Whalegun